Skip to main navigation Skip to search Skip to main content

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma

  • Wen Xue
  • , Alexander Krasnitz
  • , Robert Lucito
  • , Raffaella Sordella
  • , Linda VanAelst
  • , Carlos Cordon-Cardo
  • , Stephan Singer
  • , Florian Kuehnel
  • , Michael Wigler
  • , Scott Powers
  • , Lars Zender
  • , Scott W. Lowe
  • Cold Spring Harbor Laboratory
  • Columbia University
  • Heidelberg University 
  • Hannover Medical School
  • Helmholtz Centre for Infection Research
  • Howard Hughes Medical Institute

Research output: Contribution to journalArticlepeer-review

170 Scopus citations

Abstract

Deletions on chromosome 8p are common in human tumors, suggesting that one or more tumor suppressor genes reside in this region. Deleted in Liver Cancer 1 (DLC1) encodes a Rho-GTPase activating protein and is a candidate 8p tumor suppressor. We show that DLC1 knockdown cooperates with Myc to promote hepatocellular carcinoma in mice, and that reintroduction of wildtype DLC1 into hepatoma cells with low DLC1 levels suppresses tumor growth in situ. Cells with reduced DLC1 protein contain increased GTP-bound RhoA, and enforced expression a constitutively activated RhoA allele mimics DLC1 loss in promoting hepatocellular carcinogenesis. Conversely, down-regulation of RhoA selectively inhibits tumor growth of hepatoma cells with disabled DLC1. Our data validate DLC1 as a potent tumor suppressor gene and suggest that its loss creates a dependence on the RhoA pathway that may be targeted therapeutically.

Original languageEnglish
Pages (from-to)1439-1444
Number of pages6
JournalGenes and Development
Volume22
Issue number11
DOIs
StatePublished - Jun 1 2008

Keywords

  • DLC1
  • HCC
  • Mouse model
  • RhoA
  • RNAi

Fingerprint

Dive into the research topics of 'DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this